A Study in Participants With Moderate to Severe Rheumatoid Arthritis

NCT01711359 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

588

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Baricitinib
DRUG: Methotrexate
DRUG: Baricitinib Placebo
DRUG: MTX Placebo
DRUG: Folic Acid

Sponsor

Eli Lilly and Company